bluebird bio Inc. (BLUE) - Kapitalisasi marang bathi

bluebird bio Inc. - logo grafis emiten BLUE

This daily price chart illustrates the price action of bluebird bio, Inc., whose business remains independent of GDP cycles given the critical nature of developing treatments for genetic pathologies. The current P/E ratio is -0.20. The company relies on alliances with clinics and insurers to expand therapy coverage; however, a severe liquidity shortage and narrow specialization necessitate an urgent shift in sales strategy.

BLUE - Pangali P/E bluebird bio ing rentang 04.07.2022 - 07.06.2025

Rincian metrik komprehensif lan analitis bluebird bio (BLUE)

Analisis umum perusahaan:bluebird bio - BLUE
Barang unggulan bluebirdbio.com

The P/E ratio determines the market value of a single unit of profit, reflecting investor expectations for capital return. The metric's value depends directly on quarterly profitability and tax adjustments. By analyzing the P/E multiple under IFRS, one can assess the degree of overpayment for an asset. For bluebird bio, Inc. (BLUE), this indicator is critical due to the high cost of gene therapy. The valuation reflects the monetization potential of unique treatment methods for rare blood diseases.

Pesaing wigati

tempus.com - Kapitalisasi marang bathi resik|Pangali P/E QGEN|Periode bali modal bisnis Isis Pharmaceuticals|Pangali P/E RGEN (repligen.com)|Rasio rega pasar marang bathi resik RNA (Avidity Biosciences, Inc.)|CRSP - Rasio rega marang bathi|Nilai perusahaan marang bathi resik WGS (GeneDx)|RARE: Pangali P/E|Beam Therapeutics Corp - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi SRPT|twistbioscience.com (TWST) - Periode bali modal bisnis|Pangali P/E TXG|NTLA (Intellia) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Stoke STOK|BioLife (BLFS) - Kapitalisasi marang bathi|wavelifesciences.com - Pangali P/E|Kapitalisasi marang bathi resik MAZE|SION: Pangali P/E|PRME - Periode bali modal bisnis|Koefisien rega marang bathi TSHA|QURE - Rasio kapitalisasi marang bathi resik|Pangali P/E MGTX|Periode bali modal bisnis regenxbio.com|Pangali P/E SLDB (Solid Biosciences Inc)|OCGN: Pangali rega marang bathi|PACB - Rasio rega marang bathi|Benitec (BNTC) - Koefisien rega marang bathi|DSGN: Pangali P/E|RCKT: Rasio rega pasar marang bathi resik|FDMT (4D Molecular Therapeutics, Inc.) - Pangali P/E|lexeotx.com (LXEO) - Periode bali modal bisnis|Pangali P/E KRRO|Koefisien rega marang bathi Editas Medicine, Inc. EDIT|Rasio rega marang bathi silence-therapeutics.com SLN|PRQR: Pangali rega marang bathi|CDXS - Rasio rega marang bathi|Periode bali modal bisnis Sangamo Therapeutics, Inc. SGMO|NAUT (nautilus.bio) - Koefisien rega marang bathi|Kapitalisasi marang bathi Metagenomi, Inc. (MGX)|Koefisien rega marang bathi DTIL|Pangali rega marang bathi GBIO (generationbio.com)|Rasio rega marang bathi Boundless Bio, Inc (BOLD)|Pangali P/E Exicure Inc. (XCUR)|Imunon, Inc. - Koefisien rega marang bathi|PHIO: Pangali rega marang bathi|MBIO - Rasio rega marang bathi|Kapitalisasi marang bathi resik RNAZ|Bionano Genomics, Inc. (BNGO) - Rasio rega marang bathi|Applied DNA Sciences, Inc. (APDN) - Pangali P/E|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd.|Kapitalisasi marang bathi Omega OMGA|Pangali P/E OMIC|RGLS - Kapitalisasi marang bathi|Syros Pharmaceuticals, Inc - Koefisien rega marang bathi|Periode bali modal bisnis Codex DNA (TBIO)|TCON - Rasio rega marang bathi|UBX: Rasio rega marang bathi